On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee (PCAC) is meeting to consider whether certain peptides, including KPV, should be added to the 503A Bulks List, which is a list of drug substances that the FDA has approved for compounding
MicroRNAs in hyperglycemia induced endothelial cell dysfunction
At Longevity Health Clinic, dosing and route are individualized based on the problem being treated, the patients medical history, risk factors, goals, and response
These may play a key role in the high increased half life of the Semaglutide-GLP-1R complex (165+ hours, compared to the ~13 hours in the case of Liraglutide)
Most skin types tolerate GHK-Cu well, though a patch test or professional skin assessment is always recommended before starting, particularly for sensitive or reactive skin